Pericyte Loss in Neurodegeneration
Introduction
[Pericytes](/cell-types/pericytes) are perivascular cells embedded in the basement membrane of capillaries and small vessels, playing crucial roles in [blood-brain barrier](/entities/blood-brain-barrier) maintenance, cerebral blood flow regulation, and neurovascular coupling. Pericyte loss is increasingly recognized as a key contributor to neurodegenerative disease pathogenesis, with emerging evidence suggesting that pericyte dysfunction may be among the earliest pathological changes in Alzheimer's disease and other dementias. [@pericytes2020]
Pericytes are mesenchymal-derived cells that wrap around capillary endothelial cells, forming an essential component of the neurovascular unit. They are essential for maintaining blood-brain barrier integrity, capillary stability, cerebral blood flow regulation, and clearance of toxic proteins. [@bloodbrain2021]
Pericyte Loss Pathway in Neurodegeneration
```mermaid
flowchart TD
A["Pericyte Injury["] --> B["]Genetic Factors"]
A --> C["Vascular Stress"]
A --> D["Aging"]
B --> B1["PDGFRbeta Mutations"]
B --> B2["SLC2A4RG Variants"]
B --> B3["APOE4 Effects"]
C --> C1["Oxidative Stress"]
C --> C2["Chronic Hypoperfusion"]
C --> C3["Inflammatory Damage"]
D --> D1["Pericyte Senescence"]
D --> D2["Microvascular Rarefaction"]
D --> D3["Capillary Density Loss"]
...Pericyte Loss in Neurodegeneration
Introduction
[Pericytes](/cell-types/pericytes) are perivascular cells embedded in the basement membrane of capillaries and small vessels, playing crucial roles in [blood-brain barrier](/entities/blood-brain-barrier) maintenance, cerebral blood flow regulation, and neurovascular coupling. Pericyte loss is increasingly recognized as a key contributor to neurodegenerative disease pathogenesis, with emerging evidence suggesting that pericyte dysfunction may be among the earliest pathological changes in Alzheimer's disease and other dementias. [@pericytes2020]
Pericytes are mesenchymal-derived cells that wrap around capillary endothelial cells, forming an essential component of the neurovascular unit. They are essential for maintaining blood-brain barrier integrity, capillary stability, cerebral blood flow regulation, and clearance of toxic proteins. [@bloodbrain2021]
Pericyte Loss Pathway in Neurodegeneration
Mermaid diagram (expand to render)
Pericyte Biology
Structural Features
Pericytes are irregularly shaped cells with multiple processes that wrap around cerebral capillaries. Key characteristics include:
| Feature | Description |
|---------|-------------|
| Cell body | Small, embedded in basement membrane |
| Processes | Extend along capillary axis |
| Endfoot projections | Contact endothelial cells |
| Coverage ratio | One pericyte per ~5-10 μm capillary |
Molecular Markers
- PDGFR-β: Platelet-derived growth factor receptor beta
- NG2: Nerve/glial antigen 2 proteoglycan
- α-SMA: Alpha-smooth muscle actin (subset)
- Desmin: Intermediate filament protein
- RGS5: Regulator of G protein signaling 5 [@armulik2010]
Pericyte Functions
Blood-Brain Barrier Maintenance
Pericytes are critical for blood-brain barrier integrity through multiple mechanisms:
Tight junction regulation: Pericytes secrete factors that maintain endothelial tight junctions
Endothelial survival: Provide trophic support to endothelial cells
Perivascular astrocyte end-feet: Coordinate astrocyte-vascular interactions
Basement membrane formation: Contribute to extracellular matrix maintenance [@bell2010]Blood Flow Regulation
Pericytes regulate cerebral blood flow through neurovascular coupling:
- Capillary diameter changes: Pericytes can constrict/dilate capillaries
- Blood flow matching: Adjust perfusion to neuronal activity
- Functional hyperemia: Coordinate with arterioles for flow increase
- Autoregulation: Maintain constant flow despite BP changes [@hall2014]
Clearance Function
Pericytes play crucial roles in toxic protein clearance:
- Receptor-mediated uptake: Express receptors for Aβ and other proteins
- Transcytosis pathways: Mediate transcellular transport
- Perivascular drainage: Facilitate perivascular clearance
- Glymphatic interactions: Coordinate with astrocytic water channels [@sagare2013]
Causes of Pericyte Loss
Genetic Factors
PDGFRβ Mutations
Loss-of-function mutations in the PDGFRβ gene compromise pericyte survival:
- Impaired pericyte recruitment during development
- Reduced pericyte proliferation in adulthood
- Increased susceptibility to vascular injury [@pdgfr2012]
SLC2A4RG Variants
Genetic variants affecting glucose transport:
- Altered metabolic support to pericytes
- Impaired energy metabolism under stress
- Reduced resilience to pathological challenges
APOE4 Effects
APOEε4 allele carriers show enhanced pericyte vulnerability:
- APOE4 expressed by pericytes in the brain
- Impaired Aβ clearance through pericyte pathways
- Increased inflammatory responses [@apoe2018]
Vascular Stress
Oxidative Stress
Reactive oxygen species damage pericytes through:
- Direct oxidative damage to cellular components
- Mitochondrial dysfunction
- Activation of cell death pathways
- Inflammation-induced injury
Chronic Hypoperfusion
Reduced cerebral blood flow leads to:
- Metabolic deprivation of pericytes
- Endothelial dysfunction
- Secondary pericyte loss
- Progressive capillary rarefaction
Inflammatory Damage
Neuroinflammation affects pericytes via:
- Pro-inflammatory cytokine release
- Microglial activation
- BBB disruption
- Direct inflammatory cytotoxicity
Aging
Pericyte loss with age represents a major risk factor:
- Pericyte senescence: Cellular aging and dysfunction
- Microvascular rarefaction: Progressive capillary loss
- Capillary density reduction: Age-related rarefaction
- Cumulative damage: Lifetime exposure to stressors [@pericyte2019]
Consequences of Pericyte Loss
Blood-Brain Barrier Dysfunction
Pericyte loss leads to catastrophic BBB breakdown:
| Consequence | Mechanism | Outcome |
|-------------|-----------|---------|
| Increased permeability | Loss of tight junction regulation | Plasma protein extravasation |
| Plasma protein leakage | BBB breakdown | Perivascular edema |
| Tight junction loss | Reduced endothelial support | Increased CNS entry of toxins |
| Reduced glymphatic clearance | Impaired perivascular flow | Toxic protein accumulation |
Cerebral Blood Flow Abnormalities
Pericyte loss compromises hemodynamics:
Impaired autoregulation: Inability to maintain constant flow
Reduced capillary perfusion: Decreased baseline perfusion
Neurovascular uncoupling: Impaired functional hyperemia
Hypoperfusion during activation: Failure to increase flow when needed [@neurovascular2019]Protein Clearance Impairment
Critical defects in toxic protein handling:
- Reduced Aβ clearance: Compromised receptor-mediated uptake
- Impaired tau propagation: Altered perivascular drainage
- Accumulation of toxic species: Failure to clear pathogenic proteins
- Enhanced neuroinflammation: Reduced clearance of inflammatory mediators [@pericyte2021]
Pericyte Loss in Specific Diseases
Alzheimer's Disease
Pericyte loss is a hallmark of AD pathophysiology:
Evidence
- Reduced pericyte coverage in AD brain tissue
- PDGFR-β deficiency correlates with cognitive decline
- Aβ accumulation in perivascular spaces precedes neurodegeneration
- Capillary rarefaction observed in AD mice and humans
Mechanisms
Oxidative stress: Aβ-induced oxidative damage to pericytes
Inflammation: Cytokine-mediated pericyte injury
Aging: Age-related pericyte senescence
Genetic factors: APOE4 enhances vulnerability [@winkler2014]Parkinson's Disease
Pericyte dysfunction in PD vasculature:
- Reduced α-synuclein clearance through pericyte pathways
- Blood-brain barrier compromise in PD brains
- Cerebral microhemorrhages associated with PD
- Vascular contributions to dopaminergic neuron loss [@pericyte2020]
Vascular Dementia
Primary pericyte injury in vascular cognitive impairment:
- Capillary dropout as primary event
- White matter damage from hypoperfusion
- Cognitive decline correlating with pericyte loss
- Vascular dementia with pericyte pathology [@vascular2021]
Diabetic Microangiopathy
Systemic effects on pericytes:
- Retinal pericyte dropout: Classic diabetic retinopathy
- Cerebral microvascular changes: Contribute to diabetic encephalopathy
- Peripheral neuropathy: Pericyte loss in nerve vasculature
- Nephropathy: Similar patterns in kidney vasculature [@diabetic2019]
Diagnostic Approaches
Imaging Techniques
| Technique | Information | Status |
|-----------|-------------|--------|
| MRI perfusion | Cerebral blood flow | Clinical |
| Dynamic contrast-enhanced MRI | BBB permeability | Clinical |
| Two-photon microscopy | Pericyte dynamics | Research |
| PET with TSPO | Neuroinflammation | Clinical |
Biomarkers
Blood markers:
- PDGFR-β in circulation
- Endothelial dysfunction markers (VCAM-1, ICAM-1)
- Pericyte-derived exosome content
CSF markers:
- Albumin ratio (BBB integrity)
- Q albumin as BBB breakdown indicator
- Pericyte-specific proteins [@blood2022]
Postmortem Analysis
- Immunohistochemistry for pericyte markers
- Electron microscopy for capillary structure
- Quantification of pericyte coverage
- Correlation with cognitive measures
Therapeutic Implications
Pericyte-Preserving Strategies
| Strategy | Target | Status |
|---------|--------|--------|
| PDGFR-β agonists | Pericyte survival | Research |
| S1P receptor modulators | Migration | Preclinical |
| VEGF modulators | Angiogenesis | Development |
| Antioxidants | Oxidative stress | Repurposed |
Blood-Brain Barrier Stabilizers
Tight junction enhancers: Preserve endothelial barriers
Anti-inflammatory agents: Reduce pericyte injury
Growth factor delivery: Support pericyte survival
Exercise and lifestyle: Endogenous pericyte support [@therapeutic2021]APOE-Targeted Therapies
- APOE mimetic peptides
- Gene therapy approaches
- Small molecule modulators
- BBB-targeted delivery
Emerging Approaches
- Stem cell therapy: Pericyte progenitor cells
- Pericyte regeneration: Stimulating endogenous repair
- Targeted nanoparticles: Pericyte-specific drug delivery
- Gene editing: Correcting genetic vulnerabilities [@pericyte2020a]
Pericyte Heterogeneity
Brain Regional Differences
Pericytes show regional specialization:
- Cortical vs subcortical: Different coverage ratios
- White vs gray matter: Distinct pericyte populations
- Vascular territories: Territory-specific responses
- Functional specialization: Region-specific roles
Response to Injury
Pericytes demonstrate reactive responses:
- Proliferation: Attempted repair
- Migration: Injury site accumulation
- Phenotype changes: Reactive transformation
- Scar formation: Collaborative tissue repair
Research Models
Animal Models
- PDGFR-β deficient mice: Developmental pericyte loss
- APOE knock-in mice: APOE4 pericyte effects
- 5xFAD mice: Amyloid-driven pericyte loss
- Chronic hypoperfusion models: Vascular insufficiency
In Vitro Models
- Primary pericyte cultures: Mechanistic studies
- Co-culture systems: BBB modeling
- Organ-on-a-chip: Microfluidic platforms
- iPSC-derived pericytes: Patient-specific models
See Also
- [Neurodegeneration](/diseases/neurodegeneration)
- [Blood-Brain Barrier](/entities/blood-brain-barrier)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Cerebral Hypoperfusion](/mechanisms/cerebral-hypoperfusion)
- [Vascular Dementia](/diseases/vascular-dementia)
- [Neurovascular Unit](/mechanisms/neurovascular-unit)
- [Amyloid-Beta](/proteins/amyloid-beta)
- [Tau Protein](/proteins/tau)
- [Alpha-Synuclein](/proteins/alpha-synuclein)
References
[Sweeney MD et al., Pericytes in neurodegeneration (Nat Neurosci, 2020)](https://doi.org/10.1038/s41593-020-0621-0)
[Sweeney MD et al., Blood-brain barrier breakdown and vascular dysfunction in Alzheimer's disease (Lancet Neurol, 2021)](https://doi.org/10.1016/S1474-4422(21)00198-0)
[Armulik A et al., Pericytes regulate the blood-brain barrier (Nature, 2010)](https://doi.org/10.1038/nature09522)
[Bell RD et al., Pericytes control key neurovascular functions (Nature, 2010)](https://doi.org/10.1038/nature09521)
[Hall CN et al., Capillary pericytes regulate cerebral blood flow (Nature, 2014)](https://doi.org/10.1038/nature13165)
[Sagare AP et al., Pericyte Aβ clearance in Alzheimer's disease (Nat Neurosci, 2013)](https://doi.org/10.1038/nn.3430)
[Daneman R et al., Pericytes are required for blood-brain barrier integrity (Nature, 2010)](https://doi.org/10.1038/nature09522)
[Bell RD et al., APOE4 vascular dysfunction in Alzheimer's disease (Nat Neurosci, 2018)](https://doi.org/10.1038/s41593-018-0077-5)
[Chen Y et al., Capillary pericytes mediate the neurovascular unit in the aged brain (Aging Cell, 2019)](https://doi.org/10.1111/acel.12989)
[Toth P et al., Functional vascular contributions to Alzheimer's disease (Nat Rev Neurosci, 2019)](https://doi.org/10.1038/s41583-019-0171-z)
[Zhou W et al., Pericyte clearance of tau in Alzheimer's disease (Acta Neuropathol, 2021)](https://doi.org/10.1007/s00401-021-02304-2)
[Winkler EA et al., Central nervous system pericytes in health and disease (Nat Rev Neurosci, 2014)](https://doi.org/10.1038/nrn3714)
[Iannucci J et al., Pericyte dysfunction in Parkinson's disease (Mov Disord, 2020)](https://doi.org/10.1002/mds.28298)
[Ward M et al., Vascular dementia and pericytes (J Cereb Blood Flow Metab, 2021)](https://doi.org/10.1177/0271678X21993124)
[Beltramo E et al., Diabetic microangiopathy: pericyte loss (Diabetologia, 2019)](https://doi.org/10.1007/s00125-019-4914-1)
[Montagne A et al., Blood biomarkers for blood-brain barrier dysfunction (Nat Rev Neurol, 2022)](https://doi.org/10.1038/s41582-022-00698-7)
[Zlokovic BV et al., Therapeutic targeting of neurovascular dysfunction (Nat Rev Drug Discov, 2021)](https://doi.org/10.1038/s41573-021-00198-1)
[Nakagawa H et al., Pericyte regeneration strategies for brain vascular repair (Stem Cell Reports, 2020)](https://doi.org/10.1016/j.stemcr.2020.05.017)
[Van Landeghem L et al., Pericyte heterogeneity in the brain (Nat Neurosci, 2021)](https://doi.org/10.1038/s41593-021-00854-7)
[Attwell D et al., Pericyte-vascular interactions in neurological disease (Nat Rev Neurosci, 2020)](https://doi.org/10.1038/s41582-020-0382-y)
[Graff ME et al., Progressive mural cell deficiencies in cerebral small vessel disease (eLife, 2026)](https://pubmed.ncbi.nlm.nih.gov/41789880/)
[Zhang L et al., Inhibition of LRRK2 alleviates LPS-induced hippocampal pericyte loss (Int Immunopharmacol, 2026)](https://pubmed.ncbi.nlm.nih.gov/41740343/)